Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
125.2 USD | -0.13% | -0.75% | +14.85% |
01:41pm | Leerink Partners Raises Merck's Price Target to $134 From $129 | MT |
Apr. 15 | Zacks Adjusts Price Target on Merck & Company to $132 From $128 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.85% | 317B | |
+27.97% | 672B | |
+23.64% | 550B | |
-7.02% | 351B | |
+6.25% | 292B | |
+2.19% | 211B | |
-0.40% | 203B | |
-9.98% | 194B | |
-11.81% | 144B | |
-8.80% | 141B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Merck & Co. Says No Direct Evidence of COVID-19 Pill Leading to New Variants